Periprocedural myocardial injury during elective percutaneous coronary intervention: is it important and how can it be prevented?

被引：63

作者：

Cuculi, F. ^{[1
]}

Lim, C. C. S. ^{[1
]}

Banning, A. P. ^{[1
]}

机构：

[1] Oxford Radcliffe Hosp, Dept Cardiol, Oxford, England

来源：

HEART | 2010年 / 96卷 / 10期

关键词：

CREATINE-KINASE-MB; INTRACORONARY BETA-BLOCKER; STATIN THERAPY; UNFRACTIONATED HEPARIN; UNIVERSAL DEFINITION; RANDOMIZED-TRIAL; CLINICAL-TRIAL; TROPONIN-T; CLOPIDOGREL PRETREATMENT; ANTIPLATELET THERAPY;

D O I：

10.1136/hrt.2009.186189

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Periprocedural myocardial injury (PMI) is common after percutaneous coronary intervention (PCI). Periprocedural infarction (myocardial infarction type 4a) occurs after at least 10% of PCI procedures and has an impact on long-term prognosis. Measurement of biomarkers to allow assessment of PMI is an important tool for clinical and research purposes and should be routine after every PCI (troponin I or T and CK-MB). The importance of oral and intravenous antiplatelet agents and other drugs which have been proven to reduce PMI is discussed.

引用

页码：736 / 740

页数：5

共 66 条

[1] Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions
Abdelmeguid, AE
Topol, EJ
Whitlow, PL
Sapp, SK
Ellis, SG
[J]. CIRCULATION, 1996, 94 (07) : 1528 - 1536
[2] [Anonymous], N ENGL J MED
[3] Effect of Intracoronary Nicardipine on Cardiac Enzymes After Elective Percutaneous Coronary Intervention
Arora, Sandeep
Alfayoumi, Facli
Khawaja, Azimuddin Tareq
Dua, Aashish
Srinivasan, Venkatraman
Gradman, Alan H.
[J]. CLINICAL CARDIOLOGY, 2009, 32 (06) : 315 - 320
[4] ASPIRIN AND DIPYRIDAMOLE IN THE PREVENTION OF ACUTE CORONARY-THROMBOSIS COMPLICATING CORONARY ANGIOPLASTY
BARNATHAN, ES
SCHWARTZ, JS
TAYLOR, L
LASKEY, WK
KLEAVELAND, JP
KUSSMAUL, WG
HIRSHFELD, JW
[J]. CIRCULATION, 1987, 76 (01) : 125 - 134
[5] Effect of additional temporary glycoprotein IIb/IIIa receptor inhibition on troponin release in elective percutaneous coronary interventions after pretreatment with aspirin and clopidogrel (TOPSTAR trial)
Bonz, AW
Lengenfelder, B
Strotmann, J
Held, S
Turschner, O
Harre, K
Wacker, C
Waller, C
Kochsiek, N
Meesmann, M
Neyses, L
Schanzenbächer, P
Ertl, G
Voelker, W
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (04) : 662 - 668
[6] Novel Approaches for Preventing or Limiting Events (Naples) II Trial Impact of a Single High Loading Dose of Atorvastatin on Periprocedural Myocardial Infarction
Briguori, Carlo
Visconti, Gabriella
Focaccio, Amelia
Golia, Bruno
Chieffo, Alaide
Castelli, Alfredo
Mussardo, Marco
Montorfano, Matteo
Ricciardelli, Bruno
Colombo, Antonio
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (23) : 2157 - 2163
[7] Myonecrosis after revascularization procedures
Califf, RM
Abdelmeguid, AE
Kuntz, RE
Popma, JJ
Davidson, CJ
Cohen, EA
Kleiman, NS
Mahaffey, KW
Topol, EJ
Pepine, CJ
Lipicky, RJ
Granger, CB
Harrington, RA
Tardiff, BE
Crenshaw, BS
Bauman, RP
Zuckerman, BD
Chaitman, BR
Bittl, JA
Ohman, EM
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) : 241 - 251
[8] The impact of statin treatment on presentation mode and early outcomes in acute coronary syndromes
Cuculi, F.
Radovanovic, D.
Eberli, F. R.
Stauffer, J. C.
Bertel, O.
Erne, P.
[J]. CARDIOLOGY, 2008, 109 (03) : 156 - 162
[9] Glycoprotein IIb/IIIa Inhibitors Improve Outcome After Coronary Stenting in Clopidogrel Nonresponders A Prospective, Randomized Study
Cuisset, Thomas
Frere, Corinne
Quilici, Jacques
Morange, Pierre-Emmanuel
Mouret, Jean-Philippe
Bali, Laurent
Moro, Pierre-Julien
Lambert, Marc
Alessi, Marie-Christine
Bonnet, Jean Louis
[J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2008, 1 (06) : 649 - 653
[10] Does adenosine prevent myocardial micronecrosis following percutaneous coronary intervention? The ADELINE pilot trial
Desmet, WJR
Dens, J
Coussement, P
Van de Werf, F
[J]. HEART, 2002, 88 (03) : 293 - 295

← 1 2 3 4 5 6 7 →